GRIFOLS traded at 17.56 this Tuesday July 5th, decreasing 0.28 or 1.54 percent since the previous trading session. Looking back, over the last four weeks, GRIFOLS lost 8.11 percent. Over the last 12 months, its price fell by 21.61 percent. Looking ahead, we forecast GRIFOLS to be priced at 18.02 by the end of this quarter and at 16.28 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
17.56
Daily Change
-1.54%
Yearly
-21.61%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Alcon AG 67.84 -0.12 -0.18% 3.92%
Almirall SA 10.87 0.08 0.74% -28.01%
Amarin 1.59 0.15 10.42% -62.50%
Amadeus IT 51.36 -1.08 -2.06% -13.51%
argenx SE 368.10 6.80 1.88% 39.43%
Artemis Alpha 298.00 1.46 0.49% -33.18%
AstraZeneca 10,800.00 -8.00 -0.07% 23.84%
Bayer 55.52 -1.72 -3.00% 9.55%
Cie Automotive 22.12 -0.82 -3.57% -12.98%
Essilor 139.50 -0.30 -0.21% -7.98%
Ence Energia y Celulosa SA 3.00 -0.23 -7.24% -13.85%
Ferrovial 24.37 -0.30 -1.22% -4.58%
Fresenius Medical Care 47.26 -0.40 -0.84% -30.19%
Fresenius 28.53 -0.79 -2.69% -34.89%
Genmab 2,407.00 54.00 2.29% -8.41%
Galapagos 54.90 1.84 3.47% -5.08%
GRIFOLS 17.56 -0.28 -1.54% -21.61%
GlaxoSmithKline 1,786.60 -16.00 -0.89% 24.57%
Hikma Pharmaceutical 1,638.00 -16.00 -0.97% -35.94%
Inditex 21.77 -0.29 -1.31% -26.70%
Merck 167.85 2.45 1.48% 1.39%
Novartis 80.91 -0.74 -0.91% -4.31%
Philips 20.07 -0.08 -0.37% -50.12%
Roche Holding 319.00 -3.60 -1.12% -9.76%
Sanofi 97.12 -1.22 -1.24% 11.93%
Smith & Nephew PLC 1,130.00 -10.00 -0.88% -28.91%
UCB 82.60 -0.04 -0.05% -6.92%
Viscofan 52.60 -0.10 -0.19% -11.22%
William Demant Holding 269.40 1.20 0.45% -26.47%

Indexes Price Day Year
ES35 7959 -202.40 -2.48% -10.17%

GRIFOLS
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.